Cardiovascular Disease as a Risk Amplifier of COVID-19 Severity and a Potential Correlations to Long-Term Gastrointestinal Sequelae.

Publication date: Sep 21, 2026

Cardiovascular disease (CVD) is a significant comorbidity influencing COVID-19 outcome. This study assesses its impact on hospitalized COVID-19 patients at Howard University Hospital. A retrospective analysis was performed on a cohort of 1,580 hospitalized predominantly African American (AA) COVID-19 patients that were classified as CVD (n = 428, 27%) and non-CVD (n = 1,152, 73%) and further stratified by race to assess demographic, clinical, and laboratory differences. CVD patients exhibited higher rates of hypertension (86% vs. 49%), diabetes (47% vs. 25%), and acute kidney injury (37% vs. 21%) compared to non-CVD patients (p 

Concepts Keywords
African American
Cardiovascular Disease
COVID-19
Gastrointestinal disease

Semantics

Type Source Name
disease MESH Cardiovascular Disease
disease MESH COVID-19
disease MESH hypertension
disease MESH acute kidney injury
disease MESH Long Covid
disease MESH Gastrointestinal disease

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *